Furthermore, during hypertension or diabetes, a deficiency of ACE2 and increased ACE/ACE2 ratio have been noted (36), and cardioprotective treatments with ACE inhibitors and Ang-II receptor blockers exert their effects partly by increasing ACE2 levels (37). Here, ACE2 is linked to diabetes mellitus.